PRODUCT DETAIL

Levosimendan Kalceks 2,5 mg/ml koncentrát na infúzny roztok

Code

0576E

MA number

41/0108/22-S

Product Form:

con inf 1x5ml/12,5 mg (liek.skl.inj.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

Therapeutic Class:

41 - CARDIACA

ATC:

C	CARDIOVASCULAR SYSTEM
C01	CARDIAC THERAPY
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CX	Other cardiac stimulants
C01CX08	Levosimendan

Shelf life:

Container:

vial

Route of admin.:

Intravenous use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	16.05.2022
Validity:	16.05.2027
Pediatric warnings:	Yes
PIL:	PIL_Levosimendan Kalceks 2,5 mg_ml koncentrát na infúzny roztok_04_2022.pdf
SPC:	SPC_Levosimendan Kalceks 2,5 mg/ml koncentrát na infúzny roztok_11_2022.pdf
Safety feature	Yes
Data update:	07.11.2022